A 4-Minute Look at Medpace Holdings

If Walmart (NYSE: WMT) wrapped up its fiscal year with strong comps in the U.S., why did the stock fall 6%? What should you do when the company you own shares of is bought by another company? In this episode of MarketFoolery, host Chris Hill and analyst Jim Gillies analyze those questions and introduce Medpace Holdings (NASDAQ: MEDP), a clinical research business more investors should know about.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.

Source Fool.com